RARE Financials: Ultragenyx Pharmaceutical Inc AI Analysis

Q: ¿Cómo se aplican los indicadores de análisis técnico a RARE?

Según el análisis técnico, Ultragenyx Pharmaceutical Inc tiene una señal agregada de Buy. Ultragenyx Pharmaceutical Inc tiene 4 señales de compra, 2 señales neutrales y 1 señales de venta.

Q: ¿Cuáles son los niveles de retroceso de Fibonacci para RARE?

El nivel de retroceso de Fibonacci de Ultragenyx Pharmaceutical Inc es entre 38.2% y 50%。

Q: ¿Cuál es el RSI de Ultragenyx Pharmaceutical Inc?

El RSI de Ultragenyx Pharmaceutical Inc es actualmente 52.48, lo que indica una condición neutral

Q: ¿Cuál es el precio de Ultragenyx Pharmaceutical Inc para los próximos 12 meses?

El precio de Ultragenyx Pharmaceutical Inc RARE para los próximos 12 meses se estima en $83.37.

Q: ¿Hasta dónde se espera que suba Ultragenyx Pharmaceutical Inc?

Según los analistas de Wall Street, se espera que Ultragenyx Pharmaceutical Inc alcance una previsión alta de $134.4.

Home

Stock

RARE

Forecast

RARE Stock Price Prediction

Ultragenyx Pharmaceutical Inc

$36.45

8.9%

$2.98

At close: Dec 03, 16:00:00 GMT-5

$36.39

-0.16%

$-0.06

Post-market: Dec 03, 20:00:00 GMT-5

Overview Forecast Earnings Dividends Financials



Features

AI Copilot for Stock & Crypto

Trading Strategies

Megabrain Investors Picks

Resources

Market

Ask AI About RARE

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for RARE in the upcoming periods. Looking toward the future, our 2026 projection indicates an average price target of $83.37. The lowest target is $35.35 and the highest is $134.4. Empower your investment choices with our cutting-edge, data-driven analysis!

RARE Stock Price Prediction Summary

Top Analyst Ratings for RARE

Based on 27 analysts giving stock ratings to RARE, updated on Sep 01, 2025

Strong Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized critical insights from expert assessments to deliver a robust outlook for RARE. Our analysts highlight strong fundamentals and favorable market sentiment, positioning RARE for significant upside potential in the near term. Based on this comprehensive expert analysis, we maintain a highly optimistic view of this stock. Our conclusion: RARE is a Strong Buy candidate.

RARE stock price ended at $33.47 on Tuesday, after rising 0.30%

On the latest trading day Dec 02, 2025, the stock price of RARE rose by 0.30%, climbing from $33.37 to $33.47. Throughout the session, the stock experienced a volatility of 2.80%, with prices fluctuating between a daily low of $33.16 and a high of $34.09. Alongside this price increase, trading volume also rose by 92.9K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 949.7K shares were traded, amounting to a market value of approximately $3.2B.

RARE Technical Signals

Technical Signals Summary

Buy Signals 4

Neutral Signals 2

Sell Signals 1

Strong Sell

Sell

Neutral

Buy

Strong Buy

RARE currently exhibits 4 buy signals and 1 sell signals. The stock has been in an uptrend since 12:00 AM, with a total price change of 0.3% during this period. Overall, the technical indicators point to a Buy outlook for the mid-term.

Bullish/Bearish Signals for RARE

Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for RARE. These insights help you make informed investment decisions.

Preguntas de seguimiento

¿Cómo se aplican los indicadores de análisis técnico a RARE?



¿Cuáles son los niveles de retroceso de Fibonacci para RARE?



¿Cuál es el RSI de Ultragenyx Pharmaceutical Inc?



¿Cuál es el precio de Ultragenyx Pharmaceutical Inc para los próximos 12 meses?



¿Hasta dónde se espera que suba Ultragenyx Pharmaceutical Inc?



Ultragenyx Pharmaceutical Inc (RARE) Price

RARE Stock Price Chart